BD (NYSE:BDX) announced today that EVP and President of Interventional, Rick Byrd, informed the company that he intends to retire.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has been recognized by the Healthcare Industry Resilience Collaborative (HIRC) as the only supplier to ...

BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health (TM) by driving innovation across medical essentials, connected care, biopharma ...

On February 5, 2025, Becton, Dickinson and Company (BD) announced plans to separate its Biosciences and Diagnostic Solutions business into an independent entity. The Biosciences and Diagnostic ...

Waters Corp. and BD announced a definitive agreement July 14 to combine BD’s Biosciences & Diagnostic Solutions businesses with the Milford, Mass.-based company. The deal is structured as a ...

A growing number of financial advisors have been leaving their broker-dealer (BD) firms to start or join a registered investment advisor (RIA), an annual industry analysis has found. The study noted ...

BD has picked a new executive to lead its planned connected care segment, as the company nears the conclusion of its years-long restructuring plan. The soon-to-be-consolidated unit is set to harbor BD ...

Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.68 in the third quarter of fiscal 2025, up 5.1% year over year. The figure topped the Zacks ...

Key market opportunities include the growing demand for home healthcare solutions due to rising chronic diseases Wearable Injectors Market Wearable Injectors Market Dublin, April 21, 2026 (GLOBE ...

FRANKLIN LAKES, N.J. & SAN DIEGO--(BUSINESS WIRE)--BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of laboratory automation ...